Close
4

Athena Athena

X

Find Ethosuximide manufacturers, exporters & distributors on PharmaCompass

PharmaCompass
API SUPPLIERS
API Suppliers

API Suppliers

US DMFs Filed

US DMFs Filed

CEP/COS Certifications

CEP/COS Certifications

JDMFs Filed

JDMFs Filed

Other Certificates

Other Certificates

0

Other Suppliers

Other Suppliers

API REF. PRICE (USD / KG)
126
INTERMEDIATES

0

DOSSIERS // FDF
USA (Orange Book)

USA (Orange Book)

Europe

Europe

Canada

Canada

Australia

Australia

South Africa

South Africa

Uploaded Dossiers

Uploaded Dossiers

GLOBAL SALES (USD Million)

U.S. Medicaid

Annual Reports

0

EXCIPIENTS
PATENTS & EXCLUSIVITIES

USFDA Orange Book Patents

0

USFDA Exclusivities

0

DIGITAL CONTENT

Blog #PharmaFlow

0

News

REF STANDARD

EDQM

USP

JP

0

Other Listed Suppliers

SERVICES

0

Looking for 77-67-8 / Ethosuximide API manufacturers, exporters & distributors?

Ethosuximide manufacturers, exporters & distributors 1

100

PharmaCompass offers a list of Ethosuximide API manufacturers, exporters & distributors, which can be sorted by GMP, USDMF, JDMF, KDMF, CEP (COS), WC, Price,and more, enabling you to easily find the right Ethosuximide manufacturer or Ethosuximide supplier for your needs.

Send us enquiries for free, and we will assist you in establishing a direct connection with your preferred Ethosuximide manufacturer or Ethosuximide supplier.

PharmaCompass also assists you with knowing the Ethosuximide API Price utilized in the formulation of products. Ethosuximide API Price is not always fixed or binding as the Ethosuximide Price is obtained through a variety of data sources. The Ethosuximide Price can also vary due to multiple factors, including market conditions, regulatory modifications, or negotiated pricing deals.

API | Excipient name

Ethosuximide

Synonyms

77-67-8, Zarontin, Etosuximida, Pyknolepsinum, 2-ethyl-2-methylsuccinimide, Ethosuxide

Cas Number

77-67-8

Unique Ingredient Identifier (UNII)

5SEH9X1D1D

About Ethosuximide

An anticonvulsant especially useful in the treatment of absence seizures unaccompanied by other types of seizures.

Ethosuximide Manufacturers

A Ethosuximide manufacturer is defined as any person or entity involved in the manufacture, preparation, processing, compounding or propagation of Ethosuximide, including repackagers and relabelers. The FDA regulates Ethosuximide manufacturers to ensure that their products comply with relevant laws and regulations and are safe and effective to use. Ethosuximide API Manufacturers are required to adhere to Good Manufacturing Practices (GMP) to ensure that their products are consistently manufactured to meet established quality criteria.

click here to find a list of Ethosuximide manufacturers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PhamaCompass.

Ethosuximide Suppliers

A Ethosuximide supplier is an individual or a company that provides Ethosuximide active pharmaceutical ingredient (API) or Ethosuximide finished formulations upon request. The Ethosuximide suppliers may include Ethosuximide API manufacturers, exporters, distributors and traders.

click here to find a list of Ethosuximide suppliers with USDMF, JDMF, KDMF, CEP, GMP, COA and API Price related information on PharmaCompass.

Ethosuximide USDMF

A Ethosuximide DMF (Drug Master File) is a document detailing the whole manufacturing process of Ethosuximide active pharmaceutical ingredient (API) in detail. Different forms of Ethosuximide DMFs exist exist since differing nations have different regulations, such as Ethosuximide USDMF, ASMF (EDMF), JDMF, CDMF, etc.

A Ethosuximide DMF submitted to regulatory agencies in the US is known as a USDMF. Ethosuximide USDMF includes data on Ethosuximide's chemical properties, information on the facilities and procedures used, and details about packaging and storage. The Ethosuximide USDMF is kept confidential to protect the manufacturer’s intellectual property.

click here to find a list of Ethosuximide suppliers with USDMF on PharmaCompass.

Ethosuximide JDMF

The Pharmaceuticals and Medical Devices Agency (PMDA) established the Japan Drug Master File (JDMF), also known as the Master File (MF), to permit Japanese and foreign manufacturers of drug substances, intermediates, excipients, raw materials, and packaging materials (‘Products’) to voluntarily register confidential information about the production and management of their products in Japan.

The Ethosuximide Drug Master File in Japan (Ethosuximide JDMF) empowers Ethosuximide API manufacturers to present comprehensive information (e.g., production methods, data, etc.) to the review authority, i.e., PMDA (Pharmaceuticals & Medical Devices Agency).

PMDA reviews the Ethosuximide JDMF during the approval evaluation for pharmaceutical products. At the time of Ethosuximide JDMF registration, PMDA checks if the format is accurate, if the necessary items have been included (application), and if data has been attached.

click here to find a list of Ethosuximide suppliers with JDMF on PharmaCompass.

Ethosuximide KDMF

In Korea, the Ministry of Food and Drug Safety (MFDS) is in charge of regulating pharmaceutical products and services.

Pharmaceutical companies submit a Ethosuximide Drug Master File in Korea (Ethosuximide KDMF) to the MFDS, which includes comprehensive information about the production, processing, facilities, materials, packaging, and testing of Ethosuximide. The MFDS reviews the Ethosuximide KDMF as part of the drug registration process and uses the information provided in the Ethosuximide KDMF to evaluate the safety and efficacy of the drug.

After submitting a Ethosuximide KDMF to the MFDS, the registered manufacturer can provide importers or distributors with the registration number without revealing confidential information to Korean business partners. Applicants seeking to register their Ethosuximide API can apply through the Korea Drug Master File (KDMF).

click here to find a list of Ethosuximide suppliers with KDMF on PharmaCompass.

Ethosuximide CEP

A Ethosuximide CEP of the European Pharmacopoeia monograph is often referred to as a Ethosuximide Certificate of Suitability (COS). The purpose of a Ethosuximide CEP is to show that the European Pharmacopoeia monograph adequately controls the purity of Ethosuximide EP produced by a given manufacturer. Suppliers of raw materials can prove the suitability of Ethosuximide to their clients by showing that a Ethosuximide CEP has been issued for it. The manufacturer submits a Ethosuximide CEP (COS) as part of the market authorization procedure, and it takes on the role of a Ethosuximide CEP holder for the record. Additionally, the data presented in the Ethosuximide CEP (COS) is managed confidentially and offers a centralized system acknowledged by numerous nations, exactly like the Ethosuximide DMF.

A Ethosuximide CEP (COS) is recognised by all 36 nations that make up the European Pharmacopoeia Convention. Ethosuximide CEPs may be accepted in nations that are not members of the Ph. Eur. at the discretion of the authorities there.

click here to find a list of Ethosuximide suppliers with CEP (COS) on PharmaCompass.

Ethosuximide NDC

National Drug Code is a comprehensive database maintained by the FDA that contains information on all drugs marketed in the US. This directory includes information about finished drug products, unfinished drug products, and compounded drug products, including those containing Ethosuximide as an active pharmaceutical ingredient (API).

Finished drug products

The FDA updates the NDC directory daily. The NDC numbers for Ethosuximide API and other APIs are published in this directory by the FDA.

Unfinished drugs

The NDC unfinished drugs database includes product listing information submitted for all unfinished drugs, such as active pharmaceutical ingredients (APIs), drugs intended for further processing and bulk drug substances for compounding.

Pharmaceutical companies that manufacture Ethosuximide as an active pharmaceutical ingredient (API) must furnish the FDA with an updated record of all drugs that they produce, prepare, propagate, compound, or process for commercial distribution in the US at their facilities.

Compounded drug products

The NDC directory also contains data on finished compounded human drug products that contain Ethosuximide and are produced by outsourcing facilities. While these outsourcing facilities are not mandated to assign a Ethosuximide NDC to their finished compounded human drug products, they may choose to do so.

click here to find a list of Ethosuximide suppliers with NDC on PharmaCompass.

Ethosuximide GMP

Ethosuximide Active pharmaceutical ingredient (API) is produced in GMP-certified manufacturing facility.

GMP stands for Good Manufacturing Practices, which is a system used in the pharmaceutical industry to make sure that goods are regularly produced and monitored in accordance with quality standards. The FDA’s current Good Manufacturing Practices requirements are referred to as cGMP or current GMP which indicates that the company follows the most recent GMP specifications. The World Health Organization (WHO) has its own set of GMP guidelines, called the WHO GMP. Different countries can also set their own guidelines for GMP like China (Chinese GMP) or the EU (EU GMP).

PharmaCompass offers a list of Ethosuximide GMP manufacturers, exporters & distributors, which can be sorted by USDMF, JDMF, KDMF, CEP (COS), WC, API price, and more, enabling you to easily find the right Ethosuximide GMP manufacturer or Ethosuximide GMP API supplier for your needs.

Ethosuximide CoA

A Ethosuximide CoA (Certificate of Analysis) is a formal document that attests to Ethosuximide's compliance with Ethosuximide specifications and serves as a tool for batch-level quality control.

Ethosuximide CoA mostly includes findings from lab analyses of a specific batch. For each Ethosuximide CoA document that a company creates, the USFDA specifies specific requirements, such as supplier information, material identification, transportation data, evidence of conformity and signature data.

Ethosuximide may be tested according to a variety of international standards, such as European Pharmacopoeia (Ethosuximide EP), Ethosuximide JP (Japanese Pharmacopeia) and the US Pharmacopoeia (Ethosuximide USP).

Inform the supplier about your product requirements, specifying if you need a product with particular monograph like EP (Ph. Eur.), USP, JP, BP, or any other quality. In addition, clarify whether you need hydrochloride (HCl), anhydricum, base, micronisatum or a specific level of purity. To find reputable suppliers, utilize the filters and select those certified by GMP, FDA, or any other certification as per your requirement.
For your convenience, we have listed synonyms and CAS numbers to help you find the best supplier. The use of synonyms and CAS numbers can be helpful in identifying potential suppliers, but it is crucial to note that they might not always indicate the exact same product. It is important to confirm the product details with the supplier before making a purchase to ensure that it meets your requirements.
Ask Us for Pharmaceutical Supplier and Partner
Ask Us, Find A Supplier / Partner
No Commissions, No Strings Attached, Get Connected for FREE

What are you looking for?

How can we help you?

The request can't be empty

Please read our Privacy Policy carefully

You must agree to the privacy policy

The name can't be empty
The company can't be empty.
The email can't be empty Please enter a valid email.
The mobile can't be empty
Post Enquiry
POST ENQUIRY